Please use this identifier to cite or link to this item:
|Title:||What should we do with asymptomatic carotid stenosis?||Austin Authors:||Abbott, Anne L;Bladin, Christopher;Levi, Christopher R;Chambers, Brian R||Affiliation:||National Stroke Research Institute, Austin Health, Heidelberg, Victoria, Australia 3081, Australia||Issue Date:||1-Feb-2007||Publication information:||International Journal of Stroke; 2(1): 27-39||Abstract:||The benefit of prophylactic carotid endarterectomy (CEA) for patients with asymptomatic severe carotid stenosis in the major randomised surgical studies was small, expensive and may now be absorbed by improvements in best practice medical intervention. Strategies to identify patients with high stroke risk are needed. If surgical intervention is to be considered the complication rates of individual surgeons should be available. Clinicians will differ in their interpretation of the same published data. Maintaining professional relationships with clinicians from different disciplines often involves compromise. As such, the management of a patient will, in part, depend on what kind of specialist the patient is referred to. The clinician's discussion with patients about this complex issue must be flexible to accommodate differing patient expectations. Ideally, patients prepared to undergo surgical procedures should be monitored in a trial setting or as part of an audited review process to increase our understanding of current practice outcomes.||Gov't Doc #:||18705984||URI:||http://ahro.austin.org.au/austinjspui/handle/1/10662||DOI:||10.1111/j.1747-4949.2007.00096.x||URL:||https://pubmed.ncbi.nlm.nih.gov/18705984||Type:||Journal Article||Subjects:||Carotid Stenosis.complications.physiopathology.surgery
Randomized Controlled Trials as Topic
|Appears in Collections:||Journal articles|
Show full item record
checked on Nov 30, 2022
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.